Meet Virscio at the 2024 ACT Annual Meeting
Visit with us during the ACT Annual Meeting and learn how we are improving clinical outcomes through improved alignment of test systems to disease biology.
Virscio is excited to announce our platinum sponsorship of the 46th American College of Toxicology (ACT) Annual Meeting, taking place from November 17-20, 2024, in Austin, Texas. This year’s conference is set to bring together leading experts in toxicology and drug development, providing a unique opportunity for collaboration, learning, and innovation.
As a dedicated supporter of the toxicology community, Virscio is committed to advancing scientific research and fostering meaningful collaborations. While we will not have a booth at the conference this year, we are actively participating through various scientific presentations and interactive sessions.
We invite you to visit our poster presentations and our exhibitor-hosted session to gain insights into our latest research findings and methodologies. In addition, our scientific team will be available during the annual meeting to discuss the details of each study, answer questions, and explore potential collaborations.
Exhibitor-Hosted Session
Mark your calendar to attend our presentation during the ACT annual meeting
Virscio will be hosting an exhibitor-hosted session during the conference. This session will provide a deep dive into our specialized preclinical capabilities, with a focus on how our GLP and non-GLP toxicology services, as well as our non-clinical capabilities, can support and enhance drug development programs.
Our experts will share real-world examples and case studies that demonstrate how Virscio’s integrated approach to toxicology and pharmacology can help accelerate the path from discovery to regulatory submission. Attendees will have the opportunity to engage with our team, ask questions, and learn more about how we can support their specific research needs.
Posters and Presentations
Don’t miss our poster presentations during the ACT annual meeting
Virscio is pleased to present five scientific posters at the 2024 ACT Annual Meeting. Our posters will cover a range of topics that highlight our expertise in preclinical research, with a particular focus on toxicology, pharmacology, and translational studies. These posters reflect our ongoing commitment to delivering high-quality, actionable data that drives drug development forward.
Expression and distribution of AAV9 and a novel AAV2 variant following intrathecal and sub-pial administration in African green monkeys
Presented by: Jennifer Cann, on behalf of Michael Weed
Poster Board Number: TBD
Date & Time: Wednesday at 12 p.m.
Explore Virscio's research on the distribution and expression of AAV9 and a novel AAV2 variant in African green monkeys, focusing on CNS-targeting gene therapies. Learn how different delivery methods affect gene therapy efficacy and neuronal transduction, aiding in the development of advanced therapeutic strategies.
Expression and distribution of AAV9 and a novel AAV2 variant following intrathecal and sub-pial administration in African green monkeys
Presented by: Jennifer Cann, on behalf of Michael Weed
Poster Board Number: TBD
Date & Time: Wednesday at 12 p.m.
Explore Virscio's research on the distribution and expression of AAV9 and a novel AAV2 variant in African green monkeys, focusing on CNS-targeting gene therapies. Learn how different delivery methods affect gene therapy efficacy and neuronal transduction, aiding in the development of advanced therapeutic strategies.
Expression and distribution of AAV9 and a novel AAV2 variant following intrathecal and sub-pial administration in African green monkeys
Presented by: Jennifer Cann, on behalf of Michael Weed
Poster Board Number: TBD
Date & Time: Wednesday at 12 p.m.
Explore Virscio's research on the distribution and expression of AAV9 and a novel AAV2 variant in African green monkeys, focusing on CNS-targeting gene therapies. Learn how different delivery methods affect gene therapy efficacy and neuronal transduction, aiding in the development of advanced therapeutic strategies.
Expression and distribution of AAV9 and a novel AAV2 variant following intrathecal and sub-pial administration in African green monkeys
Presented by: Jennifer Cann, on behalf of Michael Weed
Poster Board Number: TBD
Date & Time: Wednesday at 12 p.m.
Explore Virscio's research on the distribution and expression of AAV9 and a novel AAV2 variant in African green monkeys, focusing on CNS-targeting gene therapies. Learn how different delivery methods affect gene therapy efficacy and neuronal transduction, aiding in the development of advanced therapeutic strategies.
Expression and distribution of AAV9 and a novel AAV2 variant following intrathecal and sub-pial administration in African green monkeys
Presented by: Jennifer Cann, on behalf of Michael Weed
Poster Board Number: TBD
Date & Time: Wednesday at 12 p.m.
Explore Virscio's research on the distribution and expression of AAV9 and a novel AAV2 variant in African green monkeys, focusing on CNS-targeting gene therapies. Learn how different delivery methods affect gene therapy efficacy and neuronal transduction, aiding in the development of advanced therapeutic strategies.
Meet with us during the ACT Annual Meeting
Discover how Virscio can meet your toxicology and preclinical research needs!
We understand the value of one-on-one interactions, and we are pleased to offer attendees the chance to book meetings with Virscio’s scientific experts during the conference. These meetings provide an opportunity to discuss your research challenges, explore how Virscio’s services can support your projects, and build lasting partnerships.
To schedule a meeting with our team, please fill out the online booking form below or contact us directly. We look forward to the opportunity to connect with you and discuss how we can contribute to your success.